Post by Dana-Farber Cancer Institute

Research by Lakshmi Nayak, MD, and Caron Jacobson, MD, MMSc, helped advance a major milestone in relapsed/refractory primary CNS lymphoma: an FDA label update for axicabtagene ciloleucel, the first CAR T-cell therapy for this disease. Learn more about the science behind this milestone: https://bit.ly/4tVD8CV